Effect of Mesenchymal Stromal Cells of Different Origin on DNA Fragmentation in Rat Hippocampal Neuronal Nuclei After Ischemia-Reperfusion
DOI:
https://doi.org/10.20535/ibb.2025.9.1.315490Keywords:
ischemia-reperfusion, hippocampus, neuroapoptotic changes, flow cytometry, mesenchymal stromal cellsAbstract
Background. The treatment of cerebral blood circulation disorders remains a pressing issue due to their prevalence in the elderly. Brain tissue ischemia caused by such disorders leads to necrotic and neuroapoptotic changes. To mitigate neuroapoptosis in the ischemic zone during the subacute period of the process, neuroprotectors are used. In recent years, the neuroprotective properties of mesenchymal stromal cells (MSCs) have been actively studied.
Objective. To compare effect of MSCs of different origin and the cell lysate of human MSCs from Wharton's jelly (hWJ-MSC) on neuroapoptotic changes in the hippocampus of the rat brain after ischemia-reperfusion (IR).
Methods. A 20-minute bilateral transient IR of the internal carotid arteries was performed on 165 four-month-old male Wistar rats. Following IR modeling, MSCs derived from hWJ-MSCs, as well as human and rat adipose tissue, were injected intravenously into the femoral vein of the rats. Other groups of rats received intravenous injections of fetal rat fibroblasts and cell lysate from hWJ-MSCs. Only an intravenous injection of physiological solution was administered to the control group of rats. The level of DNA fragmentation in the nuclei of hippocampal neurons on the 7th day after IR was assessed via flow cytometry.
Results. Experimental IR caused a 4.9-fold increase in the level of fragmented DNA in the operated rats compared to the sham-operated animals. The use of MSCs of various origins and hWJ-MSC lysate reduces the intensity of DNA fragmentation in the nuclei of rat hippocampal neurons, with the most pronounced effects observed in groups treated with rat fetal fibroblasts (by 4.8 times), human adipose tissue MSCs (by 2.5 times), and hWJ-MSC cell lysate (by 2 times).
Conclusions. A persistent focus of necrotic and apoptotic death of neurons in the hippocampus of rats is formed after experimental 20-minute IR of rats' brain, as evidenced by increased levels of fragmented DNA. Intravenous transplantation of MSCs of various origin and cell lysate from hWJ-MSC demonstrated a significant effect in the IR model: neurodestruction and neuroapoptosis at the area of the ischemic brain damage get less intensive. MSCs derived from human adipose tissue demonstrated superior neuroprotective potential compared to rat adipose tissue MSCs in the IR model of the rat brain.
References
Chamorro Á, Dirnagl U, Urra X, Planas AM. Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. The Lancet Neurology. 2016;15(8):869-81. DOI: 10.1016/S1474-4422(16)00114-9
Albers GW, Marks MP, Kemp S, Christensen S, Tsai JP, Ortega-Gutierrez S, et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. New England Journal of Medicine. 2018;378(8):708-18. DOI: 10.1056/NEJMoa1713973
Nogueira RG, Jadhav AP, Haussen DC, Bonafe A, Budzik RF, Bhuva P, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine. 2018;378(1):11-21. DOI: 10.1056/NEJMoa1706442
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018;49(3):e46-e110. DOI: 10.1161/STR.0000000000000158
Kontos HA. George E. Brown memorial lecture. Oxygen radicals in cerebral vascular injury. Circulation Research. 1985;57(4):508-16. DOI: 10.1161/01.res.57.4.508
Schmidley JW. Free radicals in central nervous system ischemia. Stroke. 1990;21(7):1086-90. DOI: 10.1161/01.str.21.7.1086
Halliwell B. Reactive oxygen species and the central nervous system. Journal of Neurochemistry. 1992;59(5):1609-23. DOI: 10.1111/j.1471-4159.1992.tb10990.x
Shvedskyi VV, Khodakivskyi OA. Experimental disorder of cerebral circulation with underlying alloxan diabetes mellitus: a characteristic of the model. Bukovinian Medical Herald. 2012;16(1):150-6.
Sato M, Hashimoto H, Kosaka F. Histological changes of neuronal damage in vegetative dogs induced by 18 minutes of complete global brain ischemia: two-phase damage of Purkinje cells and hippocampal CA1 pyramidal cells. Acta Neuropathologica. 1990;80(5):527-34. DOI: 10.1007/BF00294614
Higashi Y, Aratake T, Shimizu T, Shimizu S, Saito M. Protective role of glutathione in the hippocampus after brain ischemia. International Journal of Molecular Sciences. 2021;22(15):7765. DOI: 10.3390/ijms22157765
Khodakovsky AA, Marinich LI, Bagauri OV. Peculiarities of formation of post-reperfusion damage of neurons – characteristic of the model "ischemia-reperfusion". New directions and prospects for the development of modern cerebroprotective therapy of ischemic stroke. Postgraduate Doctor. 2013;58(3):69-76.
Nam HS, Kwon I, Lee BH, Kim H, Kim J, An S, et al. Effects of mesenchymal stem cell treatment on the expression of matrix metalloproteinases and angiogenesis during ischemic stroke recovery. PLoS One. 2015;10(12):e0144218. DOI: 10.1371/journal.pone.0144218
He B, Yao Q, Liang Z, Lin J, Xie Y, Li S, et al. The Dose of Intravenously Transplanted Bone Marrow Stromal Cells Determines the Therapeutic Effect on Vascular Remodeling in a Rat Model of Ischemic Stroke. Cell Transplantation. 2016;25(12):2173-85. DOI: 10.3727/096368916X692627
Chen Y, Peng D, Li J, Zhang L, Chen J, Wang L, Gao Y. A comparative study of different doses of bone marrow-derived mesenchymal stem cells improve post-stroke neurological outcomes via intravenous transplantation. Brain Research. 2023;1798:148161. DOI: 10.1016/j.brainres.2022.148161
Kawabori M, Kuroda S, Ito M, Shichinohe H, Houkin K, Kuge Y, Tamaki N. Timing and cell dose determine therapeutic effects of bone marrow stromal cell transplantation in rat model of cerebral infarct. Neuropathology. 2013;33(2):140-8. DOI: 10.1111/j.1440-1789.2012.01335.x
Konovalov S, Moroz V, Konovalova N, Deryabina O, Shuvalova N, Toporova O, et al. The effect of mesenchymal stromal cells of various origins on mortality and neurologic deficit in acute cerebral ischemia-reperfusion in rats. Cell and Organ Transplantology. 2021;9(2):104-8. DOI: 10.22494/cot.v9i2.132
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-7. DOI: 10.1080/14653240600855905
Ichim TE, O'Heeron P, Kesari S. Fibroblasts as a practical alternative to mesenchymal stem cells. Journal of Translational Medicine. 2018;16(1):212. DOI: 10.1186/s12967-018-1536-1
Saeed H, Taipaleenmäki H, Aldahmash AM, Abdallah BM, Kassem M. Mouse embryonic fibroblasts (MEF) exhibit a similar but not identical phenotype to bone marrow stromal stem cells (BMSC). Stem Cell Reviews and Reports. 2012;8(2):318-28. DOI: 10.1007/s12015-011-9315-x
Konovalov SV, Moroz VM, Husakova IV, Deryabina OG, Tochilovskyi AA. Comparative influence of mesenchymal stromal cells of different origin on DNA fragmentation of neuronal nuclei during ischemia-reperfusion of the somatosensory cortex of the rat brain. Advances in Tissue Engineering & Regenerative Medicine: Open Access. 2023;9(1):29-33. DOI: 10.15406/atroa.2023.09.00138
Pedachenko EG, Moroz VV, Yatsyk VA, Malyar UI, Liubich LD, Egorova DM. Autologous cell using for the restoration of functional defects in patients with ischemic cerebrovascular accident. Ukrainian Interventional Neuroradiology and Surgery. 2020;33(3):83-93. DOI: 10.26683/2304-9359-2020-3(33)-83-93
Konovalov SV, Moroz VM, Deryabina OG, Konovalova NV, Toporova OK, Tochilovskyi AA, Kordium VA. Restoration of the nervous system in acute ischemia-reperfusion of the rat brain by intravenous administration of mesenchymal stromal cells of different origin. Advances in Tissue Engineering & Regenerative Medicine: Open Access. 2023;9(1):60-5. DOI: 10.15406/atroa.2023.09.00142
Knight RA, Melino G. Cell death in disease: from 2010 onwards. Cell Death & Disease. 2011;2(9):e202. DOI: 10.1038/cddis.2011.89
Lee M-C, Jin C-Y, Kim H-S, Kim J-H, Kim M-K, Kim H-I, et al. Stem cell dynamics in an experimental model of stroke. Chonnam Medical Journal. 2011;47(2):90-8. DOI: 10.4068/cmj.2011.47.2.90
Toyoshima A, Yasuhara T, Kameda M, Morimoto J, Takeuchi H, Wang F, et al. Intra-arterial transplantation of allogeneic mesenchymal stem cells mounts neuroprotective effects in a transient ischemic stroke model in rats: Analyses of therapeutic time window and its mechanisms. PLoS One. 2015;10(6):e0127302. DOI: 10.1371/journal.pone.0127302
Jurcau A, Ardelean IA. Molecular pathophysiological mechanisms of ischemia/reperfusion injuries after recanalization therapy for acute ischemic stroke. Journal of Integrative Neuroscience. 2021;20(3):727-44. DOI: 10.31083/j.jin2003078
Radak D, Katsiki N, Resanovic I, Jovanovic A, Sudar-Milovanovic E, Zafirovic S, et al. Apoptosis and acute brain ischemia in ischemic stroke. Current Vascular Pharmacology. 2017;15(2):115-22. DOI: 10.2174/1570161115666161104095522
Konovalov S, Moroz V, Deryabina O, Klymenko P, Tochylovsky A, Kordium V. The effect of mesenchymal stromal cells of various origins on morphology of hippocampal CA1 area of rats with acute cerebral ischemia. Cell and Organ Transplantology. 2022;10(2):98-106. DOI: 10.22494/cot.v10i2.144
Chavda V, Chaurasia B, Garg K, Deora H, Umana GE, Palmisciano P, et al. Molecular mechanisms of oxidative stress in stroke and cancer. Brain Disorders. 2022;5:100029. DOI: 10.1016/j.dscb.2021.100029
Obeng E. Apoptosis (programmed cell death) and its signals - A review. Brazilian Journal of Biology. 2021;81(4):1133-43. DOI: 10.1590/1519-6984.228437
Sun M-S, Jin H, Sun X, Huang S, Zhang F-L, Guo Z-N, Yang Y. Free radical damage in ischemia-reperfusion injury: An obstacle in acute ischemic stroke after revascularization therapy. Oxidative Medicine and Cellular Longevity. 2018;2018:3804979. DOI: 10.1155/2018/3804979
Zakrzewski W, Dobrzyński M, Szymonowicz M, Rybak Z. Stem cells: past, present, and future. Stem Cell Research & Therapy. 2019;10(1):68. DOI: 10.1186/s13287-019-1165-5
Ntege EH, Sunami H, Shimizu Y. Advances in regenerative therapy: A review of the literature and future directions. Regenerative Therapy. 2020;14:136-53. DOI: 10.1016/j.reth.2020.01.004
Borlongan CV. Concise Review: Stem Cell Therapy for Stroke Patients: Are We There Yet? Stem Cells Translational Medicine. 2019;8(9):983-8. DOI: 10.1002/sctm.19-0076
Kawabori M, Shichinohe H, Kuroda S, Houkin K. Clinical Trials of Stem Cell Therapy for Cerebral Ischemic Stroke. International Journal of Molecular Sciences. 2020;21(19):7380. DOI: 10.3390/ijms21197380
Zhao L-R, Willing A. Enhancing endogenous capacity to repair a stroke-damaged brain: An evolving field for stroke research. Progress in Neurobiology. 2018;163-164:5-26. DOI: 10.1016/j.pneurobio.2018.01.004
Cui L-L, Golubczyk D, Tolppanen A-M, Boltze J, Jolkkonen J. Cell therapy for ischemic stroke: Are differences in preclinical and clinical study design responsible for the translational loss of efficacy? Annals of Neurology. 2019;86(1):5-16. DOI: 10.1002/ana.25493
Gutiérrez-Fernández M, Rodríguez-Frutos B, Ramos-Cejudo J, Otero-Ortega L, Fuentes B, Vallejo-Cremades MT, et al. Comparison between xenogeneic and allogeneic adipose mesenchymal stem cells in the treatment of acute cerebral infarct: proof of concept in rats. Journal of Translational Medicine. 2015;13:46. DOI: 10.1186/s12967-015-0406-3
Chung TN, Kim JH, Choi BY, Chung SP, Kwon SW, Suh SW. Adipose-derived mesenchymal stem cells reduce neuronal death after transient global cerebral ischemia through prevention of blood-brain barrier disruption and endothelial damage. Stem Cells Translational Medicine. 2015;4(2):178-85. DOI: 10.5966/sctm.2014-0103
Asgari Taei A, Dargahi L, Khodabakhsh P, Kadivar M, Farahmandfar M. Hippocampal neuroprotection mediated by secretome of human mesenchymal stem cells against experimental stroke. CNS Neuroscience & Therapeutics. 2022;28(9):1425-38. DOI: 10.1111/cns.13886
Baharlou R, Rashidi N, Ahmadi-Vasmehjani A, Khoubyari M, Sheikh M, Erfanian S. Immunomodulatory Effects of Human Adipose Tissue-derived Mesenchymal Stem Cells on T Cell Subsets in Patients with Rheumatoid Arthritis. Iranian Journal of Allergy, Asthma and Immunology. 2019;18(1):114-9. DOI: 10.18502/ijaai.v18i1.637
Ebrahim N, Mandour YMH, Farid AS, Nafie E, Mohamed AZ, Safwat M, et al. Adipose Tissue-Derived Mesenchymal Stem Cell Modulates the Immune Response of Allergic Rhinitis in a Rat Model. International Journal of Molecular Sciences. 2019;20(4):873. DOI: 10.3390/ijms20040873
Li J, Zhang Q, Wang W, Lin F, Wang S, Zhao J. Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential. Journal of Neurology. 2021;268(11):4095-107. DOI: 10.1007/s00415-020-10138-5
Chung J-W, Chang WH, Bang OY, Moon GJ, Kim SJ, Kim S-K, et al. Efficacy and Safety of Intravenous Mesenchymal Stem Cells for Ischemic Stroke. Neurology. 2021;96(7):e1012-e1023. DOI: 10.1212/WNL.0000000000011440
Kong D, Luo J, Shi S, Huang Z. Efficacy of tanshinone IIA and mesenchymal stem cell treatment of learning and memory impairment in a rat model of vascular dementia. Journal of Traditional Chinese Medicine. 2021;41(1):133-9. DOI: 10.19852/j.cnki.jtcm.2021.01.015
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 The Author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The ownership of copyright remains with the Authors.
Authors may use their own material in other publications provided that the Journal is acknowledged as the original place of publication and National Technical University of Ukraine “Igor Sikorsky Kyiv Polytechnic Institute” as the Publisher.
Authors are reminded that it is their responsibility to comply with copyright laws. It is essential to ensure that no part of the text or illustrations have appeared or are due to appear in other publications, without prior permission from the copyright holder.
IBB articles are published under Creative Commons licence:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under CC BY 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
